Crossmark

Microdistribution and quantification of the boron neutron capture therapy drug BPA in primary cell cultures of human glioblastoma tumour by NanoSIMS

Crossref DOI link: https://doi.org/10.1039/C9AN01336A

Published Online: 2019

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Aldossari, Samar https://orcid.org/0000-0003-4392-9787
McMahon, Greg https://orcid.org/0000-0003-3175-1512
Lockyer, Nicholas P. https://orcid.org/0000-0002-9674-9395
Moore, Katie L. https://orcid.org/0000-0003-1615-7232
Funding

Funding for this research was provided by:

Ministry of Education – Kingdom of Saudi Arabi

King Saud University

Department for Business, Energy and Industrial Strategy
License Information

Accepted Manuscript valid from 2020-09-17
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Samar Aldossari (ORCID)

: Greg McMahon (ORCID)

: Nicholas P. Lockyer (ORCID)

: Katie L. Moore (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 15 July 2019; Accepted 30 August 2019; Advance Article published 17 September 2019; Version of Record published 22 October 2019